Statistical Interpretation of CA125 and Bcl-2 in Serum of Patients With Late Stage Ovarian Cancer

---

Camlica H., Duranyildiz D., Tas F., Yasasever V.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.31, sa.6, ss.585-588, 2008 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 31 Sayı: 6
• Basım Tarihi: 2008
• Doi Numarası: 10.1097/coc.0b013e318174dbd2
• Dergi Adı: AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.585-588
• Anahtar Kelimeler: statistical approach, tumor marker, CA125-Bcl-2 combination, ovarian cancer, PROGNOSTIC-SIGNIFICANCE, P53, CARCINOMA, APOPTOSIS, MARKERS, PREDICTION, REGULATORS, EXPRESSION, PROTEINS, TUMORS
• İstanbul Üniversitesi Adresli: Evet

Özet

Objectives: The present study was conducted to investigate the sensitivity, specificity, predictive values and accuracy of serum CA 125 and Bcl-2 levels and their combination in advanced epithelial ovarian cancer patients.